Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 100 Show results per page	View Search Criteria \| Help With Results

Last Modified: 1/30/2008


1.		Phase III Chemotherapy with AZQ vs BCNU for Grade III/IV Astrocytoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				no age specified								MAOP-8182

Last Modified: 4/1/1988


2.		Phase III Comparison of AZQ vs BCNU Following Full-Course Postoperative Radiotherapy in Patients with Primary Anaplastic Brain Tumors (Summary Last Modified 04/88)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 and over				NCI				DUMC-140882R5 NCI-T83-1073D, T83-1073


3.		Phase III Chemotherapy with AZQ/CCNU/CACP Administered in a Standard Sequence vs a Sequence Determined by In-Vitro Assay Results for Malignant Brain Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 to 70				NCI, NINDS				NINDS-83-N-63 NCI-T84-0415N, T84-0415


4.		Phase III Chemotherapy with AZQ vs BCNU in Adult Patients with Malignant Primary Tumors of the CNS

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 to 80								OSP-84234 NCI-V85-0081

Last Modified: 6/1/1997


5.		Phase III Chemotherapy with AZQ vs BCNU in Adult Patients with Malignant Tumors of the Central Nervous System (Summary Last Modified 06/97)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				18 to 80				NCI				OSU-8503 NCI-T85-0058D, T85-0058

Last Modified: 9/16/2005


6.		Phase III Comparison of 24-Hour AZQ Infusion vs BCNU in Adults with High-Grade Supratentorial Glioma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				18 and over				NCI				SWOG-8737 INT-0093

Last Modified: 10/6/2006


7.		Phase III Randomized Trial of Intensification with ARA-C vs Sequential ARA-C, CTX/VP-16, and DHAD/AZQ in Patients Under 60 Years Old with AML in First Remission

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				15 to 59				NCI				CLB-9222 CALGB-9222


8.		Phase I-II Chemotherapy with Aziridinylbenzoquinone for Previously Treated Acute Leukemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				no age specified								UMCC-8018

Last Modified: 11/14/2007


9.		Phase I/II Chemotherapy with Intrathecal AZQ in Patients with Malignant Meningeal Spread of Refractory Leukemia, Lymphoma, or Solid Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				over 3				NCI				NCI-83-C-0039D NCI-W83-0836, W83-0836


10.		Phase I/II Chemotherapy with AZQ for Refractory Acute Leukemia and CML in Blast Crisis

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Completed				15 and over				NCI				MDA-DT-8128 NCI-T83-0942C, T83-0942

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute